VIRBAC DANMARK A/S: Financial statements 2013
CVR: 16313637
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
VIRBAC DANMARK A/S (CVR 16313637) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK 32,788,831 and a net result of DKK 6,498,369 compared with DKK 5,133,569 the year before. That is an increase of 8.2% compared with the year before. Equity in the 2013 report amounted to DKK 14,263,265. The solvency ratio was 59.5%. The company had 15 employees in the financial year.
- Gross Profit
- DKK 32,788,831
- Profit/Loss
- DKK 6,498,369
- Equity
- DKK 14,263,265
- Total Assets
- DKK 23,960,255
- Employees
- 15
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2013 | - | 32.8 mio. | 6.5 mio. | 14.3 mio. | 15 |
| 2012 | - | 30.3 mio. | 5.1 mio. | 12.8 mio. | 13 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
VIRBAC DANMARK A/S has published its annual report for 2012. Gross profit came to DKK 30,298,744, and the net result was DKK 5,133,569.
About VIRBAC DANMARK A/S
VIRBAC DANMARK A/S is a Danish company of the type Aktieselskab based in Kolding, founded in 1992. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named PHARMALETT A/S and A/S PSE 38 NR. 1583. The management consists of Betina Ebdrup. The board consists of Enguerrand Dubois (chair), Charlotte Honor Covell and Peter Sejerkilde. The company is owned by Virbac SA. The company has 28 employees (2026). In 2025, the company reported a gross profit of DKK 59,336,583 and a net result of DKK -861,159 compared with DKK 7,280,398 the year before. Equity in the 2025 report amounted to DKK 18,787,510.